Novel Metabolic Drugs and Blood Pressure: Implications for the Treatment of Obese Hypertensive Patients?
出版年份 2013 全文链接
标题
Novel Metabolic Drugs and Blood Pressure: Implications for the Treatment of Obese Hypertensive Patients?
作者
关键词
Hypertension, Obesity, Type 2 diabetes, Blood pressure, Lorcaserin, Phentermine/topiramate combination, Sodium-glucose co-transporter-2 (SGLT2) inhibition
出版物
CURRENT HYPERTENSION REPORTS
Volume 15, Issue 5, Pages 470-474
出版商
Springer Nature
发表日期
2013-08-09
DOI
10.1007/s11906-013-0374-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis
- (2013) Louise E Robinson et al. BMJ Open
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
- (2012) Jan Bolinder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Obesity-Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment
- (2012) Lewis Landsberg et al. Journal of Clinical Hypertension
- Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension
- (2012) Jens Jordan et al. JOURNAL OF HYPERTENSION
- The FDA's Assessment of Two Drugs for Chronic Weight Management
- (2012) Eric Colman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin: A Novel Sodium-Glucose Cotransporter Type 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
- (2012) Niren K. Shah et al. PHARMACOTHERAPY
- Changes in the Prevalence, Treatment and Control of Hypertension in Germany? A Clinical-Epidemiological Study of 50.000 Primary Care Patients
- (2012) Alexander Michael Labeit et al. PLoS One
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008
- (2011) Brent M. Egan et al. CIRCULATION
- Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin: A randomized, 52-week, double-blind, active-controlled noninferiority trial
- (2011) M. A. Nauck et al. DIABETES CARE
- Fatty Kidney, Hypertension, and Chronic Kidney Disease
- (2011) Meredith C. Foster et al. HYPERTENSION
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons
- (2010) Kathleen J. Griffioen et al. CARDIOVASCULAR RESEARCH
- Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial
- (2010) M. Komajda et al. EUROPEAN HEART JOURNAL
- Lorcaserin, A 5-HT2CReceptor Agonist, Reduces Body Weight by Decreasing Energy Intake without Influencing Energy Expenditure
- (2010) Corby K. Martin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
- (2010) Clifford J Bailey et al. LANCET
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relationship Between Obesity and Diabetes in a US Adult Population: Findings from the National Health and Nutrition Examination Survey, 1999–2006
- (2010) Ninh T. Nguyen et al. OBESITY SURGERY
- Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results
- (2009) Luis M Ruilope et al. JOURNAL OF HYPERTENSION
- Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans
- (2008) Adil E. Bharucha et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Burden and Rates of Treatment and Control of Cardiovascular Disease Risk Factors in Obesity: The Framingham Heart Study
- (2008) E. A. Molenaar et al. DIABETES CARE
- Resistant Hypertension: Diagnosis, Evaluation, and Treatment
- (2008) David A. Calhoun et al. HYPERTENSION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started